导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.52% | 2061/2269 |
| 近一周 | -0.06% | 1485/2338 |
| 近一月 | -0.64% | 1332/2330 |
| 近一季 | 0.53% | 1238/2324 |
| 近半年 | 3.77% | 1832/2303 |
| 近一年 | 2.95% | 1913/2260 |
| 近两年 | 14.25% | 1444/2185 |
| 近三年 | 13.56% | 939/2063 |
| 成立以来 | 77.58% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-2.40% 2073/2331 |
1.66% 1054/2353 |
3.02% 1970/2347 |
- - |
| 2024 | 10.26% 485/2336 |
3.04% 419/2322 |
1.99% 337/2326 |
4.79% 1592/2322 |
0.12% 1034/2336 |
| 2023 | 0.60% 360/2330 |
3.46% 830/2290 |
-2.38% 1183/2303 |
0.07% 313/2318 |
-0.46% 479/2330 |
| 2022 | -5.65% 532/2299 |
-5.09% 613/2227 |
4.10% 1173/2269 |
-2.10% 439/2294 |
-2.47% 1534/2300 |
| 2021 | 8.04% 891/2205 |
0.07% 832/2009 |
4.56% 1133/2060 |
-0.25% 1109/2103 |
3.51% 765/2208 |
| 2020 | 30.47% 1137/2086 |
3.23% 346/1861 |
8.41% 1212/1950 |
6.84% 1154/2010 |
9.11% 958/2031 |
| 2019 | 17.62% 1268/1974 |
9.01% 1979/3053 |
-0.28% 1468/3201 |
2.85% 1184/1861 |
5.19% 1107/1886 |
| 2018 | - - |
- - |
-1.70% 1144/2983 |
2.54% 111/2970 |
-1.09% 679/2975 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 易方达标普生物科技美元汇A | 0.2432 | 29.46% |
| 易方达标普生物科技美元汇C | 0.2399 | 28.01% |
| 汇安行业龙头混合A | 2.4323 | 22.37% |
| 华商致远回报混合A | 1.6762 | 21.58% |
| 广发生物科技指数美元(QDII)C | 0.2047 | 18.46% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)美元现汇 | 1.3424 | 17.84% |
| 华夏上证科创板半导体材料设备主题ETF联接C | 1.2373 | 17.83% |
| 宝盈国家安全沪港深股票C | 2.1469 | 17.42% |
| 汇添富纳斯达克生物科技ETF发起式联接(QDII)人民币A | 1.3726 | 17.14% |
| 广发上海金ETF | 9.7032 | 16.81% |
| 易方达瑞祺灵活配置混合I VS. () |